TAAR1 gene: A new key to mental health

In the complex landscape of mental health research, a new peer-reviewed Viewpoint review sheds light on an underexplored genetic player: the trace amine-associated receptor 1 (TAAR1). Published in Genomic Psychiatry (ISSN: 2997-2388, Genomic Press, New York), this thought-provoking analysis suggests that mutations in the TAAR1 gene may be a crucial piece of the puzzle in understanding and treating neuropsychiatric disorders.

Like Gilead, AbbVie gets its tentacles into pact with Tentarix

The octopi at Tentarix Biotherapeutics are celebrating this morning. AbbVie plans to pay $64 million upfront for two programs out of the San Diego biotech’s

February 23, 2024

Psychedelic Research Bulletin: June 2023 – Psychedelic Alpha

Psychedelic Mechanisms of Action Two studies in mice are changing how we think about how psychedelics work. The first comes from Gul Dölen’s lab and shows how

July 10, 2023

Expectation vs. Reality: Improving the Patient Payment Experience

Ryne Natzke, Chief Revenue Officer, TrustCommerce, a Sphere Company If you’ve ever worked behind the scenes at a provider organization, you likely gained a deep

October 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.